Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Multimodal Digital Biomarkers for Evidence-Based Mental Health Decision Support and Monitoring

Objective

AIREST (Artificial-Intelligence-based Rapid Emotional Screening Test) is an AI-driven Software as a Medical Device (SaMD) in development that uses modern AI and machine-learning methods to analyse multimodal behavioural biomarkers from short voice-and-video interactions. It combines acoustic and linguistic features of speech, vocal prosody, facial-expression dynamics and simple attention-related measures into objective, quantitative indicators of mental health.The system is intended for early detection, standardised screening and diagnostic support for mental health conditions, including depressive episodes and recurrent depressive disorder, generalised anxiety disorder, mixed anxiety and depressive disorder and post-traumatic stress disorder (PTSD). By processing a few minutes of guided interaction, AIREST generates risk scores and trend indicators that can be integrated into existing clinical workflows and electronic health records.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC - HORIZON EIC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2025-UKRAINIANTECH-01

See all projects funded under this call

Coordinator

LIMITED LIABILITY COMPANY AIREST
Net EU contribution
€ 494 964,38
Address
HRYSHKA MYKHAILA ST 4 OFFICE 10/1
02072 KYIV
Ukraine
SME
Yes
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
No data